1. Home
  2. ACET vs HFFG Comparison

ACET vs HFFG Comparison

Compare ACET & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACET
  • HFFG
  • Stock Information
  • Founded
  • ACET 1947
  • HFFG 1997
  • Country
  • ACET United States
  • HFFG United States
  • Employees
  • ACET N/A
  • HFFG N/A
  • Industry
  • ACET Biotechnology: Pharmaceutical Preparations
  • HFFG Food Distributors
  • Sector
  • ACET Health Care
  • HFFG Consumer Discretionary
  • Exchange
  • ACET Nasdaq
  • HFFG Nasdaq
  • Market Cap
  • ACET 111.9M
  • HFFG 124.7M
  • IPO Year
  • ACET N/A
  • HFFG N/A
  • Fundamental
  • Price
  • ACET $0.58
  • HFFG $2.52
  • Analyst Decision
  • ACET Buy
  • HFFG
  • Analyst Count
  • ACET 4
  • HFFG 0
  • Target Price
  • ACET $8.50
  • HFFG N/A
  • AVG Volume (30 Days)
  • ACET 1.8M
  • HFFG 81.4K
  • Earning Date
  • ACET 11-05-2025
  • HFFG 11-10-2025
  • Dividend Yield
  • ACET N/A
  • HFFG N/A
  • EPS Growth
  • ACET N/A
  • HFFG N/A
  • EPS
  • ACET N/A
  • HFFG N/A
  • Revenue
  • ACET N/A
  • HFFG $1,225,541,000.00
  • Revenue This Year
  • ACET N/A
  • HFFG $4.27
  • Revenue Next Year
  • ACET N/A
  • HFFG $4.55
  • P/E Ratio
  • ACET N/A
  • HFFG N/A
  • Revenue Growth
  • ACET N/A
  • HFFG 4.10
  • 52 Week Low
  • ACET $0.45
  • HFFG $1.70
  • 52 Week High
  • ACET $1.19
  • HFFG $4.93
  • Technical
  • Relative Strength Index (RSI)
  • ACET 36.18
  • HFFG 59.98
  • Support Level
  • ACET $0.57
  • HFFG $2.20
  • Resistance Level
  • ACET $0.67
  • HFFG $2.30
  • Average True Range (ATR)
  • ACET 0.06
  • HFFG 0.10
  • MACD
  • ACET 0.00
  • HFFG 0.05
  • Stochastic Oscillator
  • ACET 26.97
  • HFFG 91.25

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About HFFG HF Foods Group Inc.

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.

Share on Social Networks: